<i>In vitro</i> evaluation of neuroprotective effect of <i>Anethum graveolens</i> and its bioactives in H<sub>2</sub>O<sub>2</sub>‐induced oxidative stress model of SH‐SY5Y and biochemical studies
Abstract Background Anethum graveolans commonly known as Dill is an herb from celery family displaying anti‐oxidant benefits. The present study focused on the potential of Anethum graveolans as a multifunctional curative remedy for AD treatment. Method Hexane (H) and ethyl acetate (EA) extracts of Dill were prepared and subjected to GC‐MS for identification of important bioactive components. H 2 O 2 was used to induce oxidative stress in SH‐SY5Y cells and evaluation was done based on neuroprotection, reduced reactive oxygen species, and restoration of mitochondrial membrane potential (MMP). Additionally, anti‐Aβ fibrilization/ oligomerization activities were also analyzed along with anti‐acetylcholinesterase activity. Result Based on GC‐MS results, 3 major components were identified apiole, carvone and dihydrocarvone (DHC). The extracts and pure compounds were assessed for their neuroprotective potential in which dose‐dependent increase in neuroprotection was observed in both extracts, apiole and carvone. Dill‐H displayed a dose‐dependent decrease in ROS levels which was more prominent than Dill‐EA extract. Pure compounds also exerted a decrease in ROS level with increasing concentration. Dill extracts (H/EA) exhibited dose‐dependent increase in mitochondrial membrane potential along with Carvone and DHC. Apiole showed less restoration of MMP compared to other pure compounds. For anti‐Aβ fibrilization activity, Dill‐EA, Carvone and Apiole show ≈40% inhibition followed by DHC (35%) and Dill‐H (30%). In MDS, maximum oligomerization inhibition was observed in DHC (26%) and apiole (14%). Dill extracts and compounds exhibit anti‐AChE activity and inhibited the enzyme through competitive inhibition except for DHC. Conclusion We focused our research on small molecules from food to prevent AD. There is a need for a drug that is easily accessible, cost‐effective and has no/fewer side effects. In our study, Dill extracts and its identified bioactive compounds exhibited a multitargeted neuroprotection in the SH‐SY5Y cells making it a promising candidate for AD drug development.
Authors
- Himadri Sharma
Institutions
- Gachon University (KR)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/alz.090623
- Primary Topic
- Phytochemical and Pharmacological Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00